# 3705
Helen Branswell of the Canadian Press tonight brings us some deep background on what can only be described as a `no-win situation’ facing public health regulators when it comes to the pandemic vaccine.
This is something we’ve discussed before: The decision to use (or not use) adjuvants in the vaccine. A few recent blogs on this subject include:
Canada To Offer Unadjuvanted Vaccine To Pregnant Women
CAMJ Editorial: The H1N1 Vaccine Race
Running Into A Public Relations Buzz Saw
More On The Adjuvant Controversy
Branswell On The Adjuvant Controversy
Ms. Branswell demonstrates, once again, why she is so highly regarded as a science reporter as she outlines the complexities of this issue.
Follow the link to read it in its entirety.
Feds between a rock and a hard place juggling speed, safety of pandemic vaccine
Published Sunday September 6th, 2009
Helen Branswell, THE CANADIAN PRESS--
TORONTO - In the race to get pandemic vaccine into Canadian arms, public health and vaccine regulatory authorities in this country find themselves the reluctant filling in a rock-and-a-hard-place sandwich, knowledgeable observers say.
Doctors who've seen how desperately sick some swine flu patients become are pressing authorities to further fast-track vaccine approval. But a large portion of the public appears reluctant to take the vaccine, a situation that could worsen if fast-tracking deepens suspicions about the product's safety.
Individuals and organizations concerned about global equity are urging countries with vaccine contracts to stretch supplies by using boosting compounds called adjuvants so developing countries can also get some serum. But the decision to use an adjuvant is being blamed - unfairly, federal officials say - for the fact Canada may not start vaccinating until a month after the U.S. and Britain.
Related Post:
- NEJM: Adjuvanted Flu Vaccine Found Effective In Children
- Pediatrics: Effectiveness Of A Single Adjuvanted Pandemic Flu Shot In Children
- BMJ: Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine
- Lancet: Immunogenicity and safety Of Adjuvanted Flu Vaccines
- BMJ: Immunogenicity Of Adjuvanted vs. Unadjuvanted H1N1 Vaccines
- Novartis To Open Next Generation Vaccine Plant In NC
- Referral: Fergus Walsh Pandemrix Vaccine Q&A
- SAGE Advice
- Canada Purchases Unadjuvanted Vaccine From CSL
- Helen Branswell’s Q&A On Adjuvants
- Branswell Reports On Canada’s Unadjuvanted Vaccine Purchase
- David Dobbs Examines The Adjuvant Controversy
- Canada To Offer Unadjuvanted Vaccine To Pregnant Women
- Anticipating The Flu Season Down Under
- ACP Calls For Health Care Worker Immunizations
- Branswell On Flu Vaccine Matches
- Flu Vaccine Still Available, But Spot Shortages Exist
- Study: Self-Administered Vaccines In Adults
- Egypt: A Paltry Poultry Vaccine
- Lancet: Low Flu Vaccine Effectiveness
- Hong Kong: H5N1 Vaccine Recommended For Certain Lab Workers
- AAP Endorses SAGE Recommendations Keeping Thimerosal In Vaccines
- NIVW 2012
- Study Supports Safety Of Tdap Vaccine In Older Patients
- JAMA: Waning Pertussis Vaccine Effectiveness Over Time
- Revisiting The Numbers Racket
- Of Pregnancy, Flu & Autism
- Canada & Switzerland Clear Novartis Flu Vaccine For Use
- CMAJ On Mandatory Flu Shot For HCWs
- Novartis Fluad And Agriflu Vaccines Suspended In Canada
- The UK’s Whooping Cough Outbreak
- Peter Sandman On the CCIVI Vaccine Report
- CIDRAP: The Need For `Game Changing’ Flu Vaccines
- Rhode Island Adopts New Flu Vaccination Requirements For HCPs
- Vietnam Reports Progress On New Bird Flu Vaccine
- WHO: Southern Hemisphere 2013 Flu Vaccine Composition
- NPM12: Giving Preparedness A Shot In The Arm
- Yes, We Have No Pandemic . . .
- Canada Releases Tamiflu From National Emergency Stockpile
- Canada: FluWatch Week 52
- Canada: Another West Coast Temblor
- Haida Gwaii Quake & Tsunami Advisories
- Novartis Fluad And Agriflu Vaccines Suspended In Canada
- Ontario Confirms H1N1v Case
- EID Journal: Revisiting The `Canadian Problem’
- Alberta, Canada Issues Measles Alert
- IDSA: Educational Guidelines Lower Antibiotic Use
- Webinar: pH1N1 – H3N2 A Novel Influenza Reassortment
- North America Flu Surveillance Week 8
- North America Influenza Surveillance - Week 4
- North America: Flu Surveillance Week 2
- North America: Flu Activity Week 1
- Toronto ERs Seeing Heavy Flu Volume
- North America: H3N2 Driving Our Flu Season
- PHAC: Lessons Learned From The 2009 Pandemic
- Ontario: A Top Ten List Of Infectious Disease Threats
- Eurosurveillance: The Temporary Immunity Hypothesis
- OIE Report: Manitoba Bird Flu Identified As H5N2
- CFIA Statement On Manitoba’s Avian Flu Outbreak
- CTV Reporting Low Path H5 On Canadian Turkey Farm
- CMAJ: Comparing First And Second Pandemic Waves In Canada
- Study: Eurosurveillance On `The Canadian Problem’
- CSA White Paper: Voices From The Front Lines
Widget by [ Iptek-4u ]